GIVAX, Inc.
Biotechnology Research
16 employees
- Employees
- 16
- Contacts
- 2
- Emails
- 2
GIVAX, Inc. Overview
- Website
- www.givax.bio
- Industry
- Biotechnology Research
- Employees
- 16
- Founded
- 2021
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About GIVAX, Inc.
GIVAX, Inc. is a biotech company that is backed by RA Ventures, the venture-focused arm of RA Capital Management, LP. GIVAX is developing novel oral vaccines to eliminate the burden of preventable GI disease in children & adults. Our lead program is a dual pediatric rotavirus / norovirus vaccine.
GIVAX, Inc. Contact Details
- People in AeroLeads
- 4
- With contact data
- 2
- Email contacts
- 2
- 50.0% coverage
GIVAX, Inc. Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Eduardo Anaya | Immunologist / Vaccine Development | Baltimore, Maryland, United States |
Email
|
| Madeline Schwarz, Ph.d. | Scientist (Virology) |
View
|
|
| Rachel Bedenbaugh, Mph | Director of Operations & Project |
View
|
|
| Fanny Cavalie | Cambridge, Massachusetts, United States |
Email
|
Employees by Management Level
Individual contributor
2 profiles
Director
1 profile
Compare Similar Companies to GIVAX, Inc.
Spark Therapeutics, Inc.
Biotechnology Research
RA Capital Management
Financial Services
Century Therapeutics, Inc
Biotechnology
Integral Molecular
Biotechnology Research
Interius BioTherapeutics
Biotechnology Research
Raven (RA Ventures)
Biotechnology Research
VintaBio
Biotechnology Research
AUM BioTech
Biotechnology Research
Biocartesian
Biotechnology Research
BioLabs for Advanced Therapeutics Philadelphia
Biotechnology Research